Liver cancer clinical trials

Explore recruiting liver cancer clinical trials.

Recruiting liver cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Liver cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

DUMELEP trial - Durvalumab (MEDI4736)/Tremelimumab in neoadjuvant and adjuvant setting in patients with HCC treated by percutaneous ablation procedure in curative intent

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Early detection of hepatocellular carcinoma by Hyperpolarized [1- 13C]pyruvate MRI

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In Combination with Ipilimumab in Participants with First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC)

Poland, Spain, Germany, France, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

HESTIA : A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function Score.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Radioembolization with Intra-arterial Angiotensin II to improve Tumor-absorbed dose: The RADIANT study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Liver cancer trials by city

Liver cancer in Toronto Liver cancer in Vancouver Liver cancer in Montreal Liver cancer in Calgary Liver cancer in Edmonton Liver cancer in Ottawa Liver cancer in Winnipeg Liver cancer in Quebec City Liver cancer in Hamilton Liver cancer in Kitchener Liver cancer in London Liver cancer in Halifax Liver cancer in New York Liver cancer in Los Angeles Liver cancer in Chicago Liver cancer in Houston

Other conditions

Prostate cancer Lung cancer Non-small cell lung cancer Colorectal cancer Pancreatic cancer Ovarian cancer Melanoma Leukemia Lymphoma Multiple myeloma Bladder cancer Kidney cancer Glioblastoma Head and neck cancer Cervical cancer Endometrial cancer Gastric cancer Age-related macular degeneration Diabetic retinopathy Glaucoma Dry eye disease HIV Hepatitis B Hepatitis C